Target intelligence / Profile preview

Gamma-glutamyltransferase light chain family member 3 (GGTLC3)

Target
GGTLC3
Molecular classification
Enzyme (putative, gamma-glutamyltransferase family), Other (gamma-glutamyltransferase light chain subfamily; lacks full catalytic activity)
01

Overview

Gamma-glutamyltransferase light chain family member 3 (GGTLC3) is a member of the gamma-glutamyltransferase (GGT) family, which includes enzymes responsible for cleaving gamma-glutamyl peptide bonds in glutathione and other peptides[1][4]. Unlike canonical GGT1, GGTLC3 contains a region homologous to the light chain subunit of GGT but lacks the heavy chain necessary for membrane anchoring and typical enzymatic activity[1][4]. As such, GGTLC3 is considered a "light chain-only" member of this family and is of uncertain or *putative* glutathione hydrolase function. While there is evidence for the involvement of canonical GGTs in glutathione metabolism, drug detoxification, and roles in certain diseases, there are currently no validated drug interactions, direct disease associations, or established roles for GGTLC3 in human physiology or as a therapeutic target[4][1][5][6]. GGTLC3 is predicted to have glutathione hydrolase activity and possible involvement in leukotriene metabolism, but this is not experimentally validated[6][4]. The gene is cataloged on chromosome 22, and its dysfunction has been reported in genetic association datasets related to rare diseases such as glutathionuria and some types of cataracts[4]. No specific biomarkers, therapeutic implications, or significant safety concerns have been established for GGTLC3 in clinical or pharmacological contexts[1][4][6].

Other names
Glutathione hydrolase light chain 3GGTLC3Gamma-glutamyltransferase light chain 3putative gamma-glutamyltransferase light chain 3putative glutathione hydrolase light chain 3GGTL3_HUMAN
02

Biological functions

*Putative* glutathione hydrolase activity*Putative* involvement in gamma-glutamyl cycle
03

Disease associations

Associations reported with GlutathionuriaCataract 34, multiple typesNo confirmed direct roles in major diseases established

Beyond the preview

Go deeper on Gamma-glutamyltransferase light chain family member 3 (GGTLC3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-glutamyltransferase light chain family member 3 (GGTLC3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call